As CCL19, the ligand of CCR7, promotes the development of PCNSL through the retention of CCR7 expressing lymphoma cells in the brain [46], the CCR7-CCL19 axis might also play a role in the evasion of malignant B cells from the brain to the CSF. This evidence concerns the gene CCR7 and primary central nervous system lymphoma.